Mandate

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.

The offering price was SEK 58 per ordinary share, corresponding to a total market value for all ordinary shares in Apotea of approximately SEK 6 billion. The total value of the offering amounts to approximately SEK 1,880 million, provided that the overallotment option is exercised in full.

Apotea is Sweden’s leading online pharmacy by market share with the goal of becoming the largest pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low prices and quick deliveries, the company facilitates everyday life for its three million active customers.

Vinge’s team primarily consisted of Jesper Schönbeck, Amanda Knutsson, Anna Svensson, Lorin Arabi, Karin Karsten and Elias Kröger (Capital Markets and Public M&A), Victor Ericsson, Emelie Svanberg, Ellenor Eckerborn och Marcus Svärd (Corporate Tax), Sam Seddigh and Emil Lindwall (Employment), Helena Rosén Andersson and Hilda Ivarsson (Permits), Fredrika Hjelmberg, Mario Saad and Siri Blomberg (Commercial agreements, IT and GDPR), Ian Jonson (Intellectual Property) and Sofia Haggren (Financing).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025